Bioplatforms Australia News

National Synthetic Biology scoping study – Brisbane and Melbourne consultation

 

In the May 2018 budget, the Commonwealth Government announced its long-term investment in support of the Australian Government National Research Infrastructure Roadmap.

The Investment Plan includes funding for a scoping study to progress work in Synthetic Biology. Bioplatforms Australia, with an expert working panel, is conducting an open forum for researchers and other stakeholders to clarify specific needs and gaps in infrastructure requirements for innovations in this field.

 

Bioplatforms Australia is visiting most capital cities in the coming months and we invite you to attend the event that is the most convenient for you.

  • The Brisbane consultation event will be held at the University of Queensland (first floor lecture theatre, Building 75, UQ, St Lucia) on Wednesday 7th November 2018, 10-11 am. Register to the Brisbane consultation event through the dedicated EventBrite page to ensure that numbers can be adequately accommodated.
  • The Melbourne consultation event will be held at the Peter MacCallum Cancer Centre (Level 11 Boardroom 11:215, Peter MacCallum Cancer Centre, 305 Grattan Street) on Monday 10th December 2018, 10 am. Registration link to follow shortly.
  • Further consultations are being finalised for Perth in early February 2019, as well as Adelaide and Canberra in the new year, with details to follow.

 

And do not forget the previously announced Sydney consultation event being held at the University of Sydney Business School on Tuesday 30 October 2018,  registration are still open on the EventBrite page.

 

Please find the National Synthetic Biology scoping study introductory presentation slides here 

 

Contact:
Natalie Curach | ncurach@bioplatforms.com

French Island Koala, picture by Greta Frankham, copyright Australian Museum

Register to the Brisbane event here

News and Media

Latest Bioplatforms News and Media

News Signup

Bioplatforms Australia

+61 0410 538 648

agilbert@bioplatforms.com